UPDATED: NYS Medicaid Reimbursement Policy for Administration of COVID-19 Testing and Monoclonal Antibody (mAb) Therapeutic Dispensing or Administration
3The New York State Department of Health has updated the following policy and billing guidance documents regarding Medicaid’s reimbursement policy for the administration of COVID-19 Testing and Specimen Collection at Pharmacies, At Home COVID-19 Testing, and COVID-19 Monoclonal Antibody (mAb) Therapeutic Dispensing or Administration at Pharmacies.
- New York State (NYS) Medicaid Fee-For-Service (FFS) Policy and Billing Guidance for COVID-19 Testing and Specimen Collection at Pharmacies
- New York State (NYS) Medicaid Pharmacy Policy and Billing Guidance for At Home COVID-19 Testing Coverage
This guidance can be found on the COVID-19 Guidance for Medicaid Providers webpage, which is updated regularly.
NYSHFA/NYSCAL CONTACTS:
Jackie Pappalardi, RN, BSN
Executive Director
518-462-4800 x16
Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15
Posted in Clinical & Quality, Finance & Reimbursement